Waydose Pharma Private Limited
About Waydose Pharma Private Limited
Data last updated:
Waydose Pharma Private Limited is a private limited company based in Ramachandrapuram, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 29 November 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21000TS2023PTC179475.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Venkata Ramana Reddy Gali and Srinivasa Rao Prathipati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ramachandrapuram, Telangana.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHno.6 – 48/1 Plot No.1/A, Sy No.163 Bhavani Puram, Ramachandrapuram, Telangana, India – 502032
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Waydose Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Waydose Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | •••• | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | •••• | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Waydose Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | •••• |
| Net Profit Margin | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Waydose Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Waydose Pharma Private Limited
Waydose Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Ramana Reddy Gali | Director | 29 Nov 2023 | 2 Years 10 Months | Current |
| Srinivasa Rao Prathipati Also directs: Inventro Labs Private Limited | Director | 25 Jan 2024 | 2 Years 8 Months | Current |
| Srinivasarao Polu | Director | 25 Jan 2024 | 2 Years 8 Months | Current |
Charges & Borrowings of Waydose Pharma Private Limited
Waydose Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Waydose Pharma Private Limited
Employment history and EPFO contributions of people linked to Waydose Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Waydose Pharma Private Limited
Waydose Pharma Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Naresh Appikatla ceased to be Director on 26 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Waydose Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Waydose Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Waydose Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Waydose Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Waydose Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Waydose Pharma Private Limited
Waydose Pharma is an active private limited company based in Ramachandrapuram, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 29 November 2023 (3+ years old) and is registered under CIN U21000TS2023PTC179475.
Waydose Pharma has 3 current directors:
- Venkata Ramana Reddy Gali - Director
- Srinivasa Rao Prathipati - Director
- Srinivasarao Polu - Director
The CIN (Corporate Identification Number) of Waydose Pharma is U21000TS2023PTC179475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Waydose Pharma was incorporated on 29 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Naresh Appikatla ceased to be Director on 26 Jan 2024. Srinivasa Rao Prathipati was appointed as Director on 25 Jan 2024. Srinivasarao Polu was appointed as Director on 25 Jan 2024. Waydose Pharma has 4 board changes on record in total.
The registered office of Waydose Pharma is at Hno.6 – 481 Plot No.1A, Sy No.163 Bhavani Puram, Ramachandrapuram, Telangana, India – 502032.
Waydose Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Waydose Pharma operates in the paper industry, in the paper and paper products segment.
No. Waydose Pharma is not listed on any stock exchange. It is an unlisted company.
The compliance status of Waydose Pharma is compliant as of 08 July 2026. The company is actively filing with the Registrar of Companies.